[Federal Register Volume 81, Number 88 (Friday, May 6, 2016)]
[Notices]
[Page 27473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10730]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Almac Clinical 
Services Incorp (ACSI)

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Almac Clinical Services Incorp (ACSI) applied to be registered 
as an importer of a certain basic class of controlled substance. The 
Drug Enforcement Administration (DEA) grants Almac Clinical Services 
Incorp (ACSI) registration as an importer of this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated December 15, 2015, and 
published in the Federal Register on December 24, 2015, 80 FR 80387, 
Almac Clinical Services Incorp (ACSI), 25 Fretz Road, Souderton, 
Pennsylvania 18964 applied to be registered as an importer of a certain 
basic class of controlled substance. No comments or objections were 
submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of Almac Clinical Services 
Incorp (ACSI) to import the basic class of controlled substance is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of Morphine (9300), a basic class of 
controlled substance listed in schedule II.
    The company plans to import the listed controlled substance in 
dosage form for clinical trial only. Approval of permit applications 
will occur only when the registrant's business activity is consistent 
with what is authorized under 21 U.S.C. 952(a)(2). Authorization will 
not extend to the import of FDA approved or non-approved finished 
dosage forms for commercial sale.

    Dated: April 29, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-10730 Filed 5-5-16; 8:45 am]
 BILLING CODE 4410-09-P